F stock · RXRX stock

F vs RXRX · rev $187.27B vs rev $58.8M

Ford Motor Company (F) versus Recursion Pharmaceuticals Inc (RXRX) — a side-by-side from cached financials, not a winner call.

Ford Motor Company (F) is a auto manufacturers company listed on US. It is led by Jim Farley.

Recursion Pharmaceuticals Inc (RXRX) is a biotechnology company listed on NASDAQ.

Latest reported F revenue for 2025-12-31 was $187.27B. Net income was -$8.16B. Revenue was up 1.2% from 2024-12-31 to 2025-12-31. F currently screens at market cap $59.37B.

Latest reported RXRX revenue for 2024-12-31 was $58.8M. Net income was -$463.7M. Revenue was up 32.0% from 2023-12-31 to 2024-12-31. RXRX currently screens at market cap $1.75B.

F currently screens at market cap $59.37B. RXRX currently screens at market cap $1.75B.

Not investment advice. Open the F and RXRX stock pages for the full models.

Not investment advice.

Popular Stock Comparisons